Light Mode
$873.71 ↑ +0.00 (+0.00%) Trading Up from the previous close of $873.71, $13.37 below the day’s high of $887.07
+93.46 (+11.98%) / 6M
Momentum, market sentiment, and recent alerts
ARGX reads neutral: price sits above one of the two key moving averages, the 12-month move is +6.9%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. It operates through the following geographical segments: United States, Japan, EMEA, and China. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren in 2008 and is headquartered in Amsterdam, the Netherlands.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.